ResMed Inc. (RMD)

SEC filing

ResMed Inc.

RMD · CIK 943819

4 · Oct 8, 2026 · Director, Chairman and CEO Farrell Michael J. sold 4,991 ResMed Common Stock at $226.33/unit ($1.1M); exercised options for 9,982 shares

Director, Chairman and CEO Farrell Michael J. sold 4,991 ResMed Common Stock at $226.33/unit ($1.1M); exercised options for 9,982 shares

Filed: Oct 8, 2026
Period: Oct 7, 2026
Accession: 0000943819-26-000085
Filer: RESMED INC (0000943819) (Issuer)

View on SEC.gov All SEC filings

Filing document

PRIMARY DOCUMENT

xslF345X06/form4.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4PRIMARY DOCUMENTform4.xml
Open SEC.gov